Drug / Chemical name: Tirilazad Mesylate
Adverse Effect / Toxicity: Cardiac failure congestive
Species: Human
Dose: 1.125 g/every 6 h/12Doses
Dose type: Repeated
Route: Intravenous
Source link
Source link
Adverse Effect / Toxicity: Cardiac failure congestive
K.C. Johnston, J.Y. Li, P.D. Lyden, S.K. Hanson, T.E. Feasby, R.J. Adams, R.E. Faught, E.C. Haley, for the R. Investigators, Medical and Neurological Complications of Ischemic Stroke Experience From the RANTTAS Trial, Stroke. 29 (1998) 447–453. doi:10.1161/01.STR.29.2.447.
